CaRe Clinic, a prominent clinical research organization based in Alberta, Canada, has officially joined the expansive global network of hyperCORE International. This strategic partnership aims to broaden the reach and capabilities of both entities in the realm of clinical trials, significantly impacting the clinical research landscape.
CaRe Clinic operates two state-of-the-art research centers located in Calgary and Red Deer, serving the central regions of Alberta. The organization specializes in a diverse range of medical fields including women's health, dermatology, general medicine, vaccines, infectious diseases, and migraine treatments. With a robust database of over 1.8 million potential patients and strong affiliations with local clinics, CaRe Clinic has established a community-centric approach to participant recruitment, enhancing their capacity to conduct comprehensive clinical trials.
Troy Hamilton, Director of Operations at CaRe Clinic, emphasized the importance of this partnership by stating, "At CaRe Clinic, we are continuously looking for opportunities to improve how we deliver clinical trials. Joining hyperCORE International was a chance to do just this. This partnership opens doors for unprecedented collaboration and the sharing of best practices across borders, which is crucial for the advancement of clinical research. We aim to highlight Canada's robust clinical research ecosystem on the global stage and contribute to pioneering breakthroughs that will benefit patients worldwide."
hyperCORE International is renowned for its extensive network, comprising highly experienced and awarded clinical research site/network companies across two continents and five countries. The organization provides Phase I-IV clinical trial services through more than 120 active research sites. Its alliance partners have collectively completed over 7,000 studies, evaluating thousands of new drugs and treatments on more than 150,000 randomized patients.
The integration of CaRe Clinic into hyperCORE's network signifies a substantial increase in hyperCORE's footprint in Canada, adding a multi-therapeutic offering and a solid partner to its team. Carlos Orantes, President of hyperCORE and CEO at alliance partner Alcanza Clinical Research, expressed his enthusiasm, stating, "hyperCORE welcomes CaRe Clinic to their super network with open arms. This immediately increases hyperCORE's footprint at multiple locations in Canada with a multi-therapeutic offering and adds a solid partner to the team. We are excited to start working closely with the CaRe Clinic team!"
hyperCORE International maintains a commitment to the highest standards of research excellence, prioritizing subject safety, data integrity, rapid study startup, competitive enrollment, and outstanding subject retention. The network's members have garnered numerous awards for their performance, quality, and innovation in clinical research.
This partnership is poised to make significant strides in the field of clinical research, fostering global collaboration and accelerating the development of new medical treatments and drugs. The alliance between CaRe Clinic and hyperCORE International represents a pivotal moment for the advancement of clinical trials, with the potential to benefit patients worldwide through innovative medical research.
